•   Exclusive

Cipla’s journey to driverless forecasting

After it transformed forecasting, pharmaceutical supplier Cipla Medpro South cut inventory levels 25% and stock-outs to less than 1%. But it almost didn't happen. The initial challenge was gathering up the courage to change.

Subscriber: Log Out

Sorry, but your login has failed. Please recheck your login information and resubmit. If your subscription has expired, renew here.

This is an excerpt of the original article. It was written for the November 2017 edition of Supply Chain Management Review. The full article is available to current subscribers.

November 2017

There are strands of sustainability and corporate responsibility through much of this month’s issue. James T. Prokopanko, the former CEO and president of The Mosaic Company, details how corporate responsibility became his compass for leader ship when he took over the reins of the company back in 2007. Similarly, Joseph Ludorf, the executive director of supply chain for Cipla Medpro, details how revamping the planning process enables the South African pharmaceutical company to prof- itably supply drugs to underserved populations on the continent as part of its corporate mission. We round out the issue with five tips for intelli- gent risk taking in…
Browse this issue archive.
Already a subscriber? Access full edition now.

Need Help?
Contact customer service
847-559-7581   More options
Not a subscriber? Start your magazine subscription.

In the business of supplying life-saving medicines, nothing matters more than getting the right items to the right places on schedule. When that doesn’t happen, poor forecasting and stock-outs are often the crux of the problem.

But the pharmaceutical supply chain is a little more complicated than managing just those planning variables at Cipla Medpro South Africa, where I am the director of supply chain operations.

We are constantly confronted with product limitations ranging from temperature control requirements to expiration dates. Both create their own supply chain challenges in Africa. And then there are the seemingly endless regulations from international and local agencies. These include standards from the World Health Organization and the South African Medicines Control Council, not to mention many local pharmaceutical and manufacturing standards.

We also have to factor in very long lead times for imported products and demand spikes from government contract tenders. And on the delivery side, we are faced with immense logistical difficulties that range from unpaved roads to armed bandits.

This complete article is available to subscribers only. Log in now for full access or start your PLUS+ subscription for instant access.

SC
MR

Sorry, but your login has failed. Please recheck your login information and resubmit. If your subscription has expired, renew here.

From the November 2017 edition of Supply Chain Management Review.

November 2017

There are strands of sustainability and corporate responsibility through much of this month’s issue. James T. Prokopanko, the former CEO and president of The Mosaic Company, details how corporate responsibility…
Browse this issue archive.
Download a PDF file of the November 2017 issue.

In the business of supplying life-saving medicines, nothing matters more than getting the right items to the right places on schedule. When that doesn't happen, poor forecasting and stock-outs are often the crux of the problem.

But the pharmaceutical supply chain is a little more complicated than managing just those planning variables at Cipla Medpro South Africa, where I am the director of supply chain operations.

We are constantly confronted with product limitations ranging from temperature control requirements to expiration dates. Both create their own supply chain challenges in Africa. And then there are the seemingly endless regulations from international and local agencies. These include standards from the World Health Organization and the South African Medicines Control Council, not to mention many local pharmaceutical and manufacturing standards.

We also have to factor in very long lead times for imported products and demand spikes from government contract tenders. And on the delivery side, we are faced with immense logistical difficulties that range from unpaved roads to armed bandits.

SC
MR

Latest Podcast
Talking Supply Chain: Doomsday never arrives for Baltimore bridge collapse impacts
The collapse of Baltimore’s Francis Scott Key bridge brought doomsday headlines for the supply chain. But the reality has been something less…
Listen in

About the Author

SCMR Staff
SCMR Staff

Follow SCMR for the latest supply chain news, podcasts and resources.

View SCMR's author profile.

Subscribe

Supply Chain Management Review delivers the best industry content.
Subscribe today and get full access to all of Supply Chain Management Review’s exclusive content, email newsletters, premium resources and in-depth, comprehensive feature articles written by the industry's top experts on the subjects that matter most to supply chain professionals.
×

Search

Search

Sourcing & Procurement

Inventory Management Risk Management Global Trade Ports & Shipping

Business Management

Supply Chain TMS WMS 3PL Government & Regulation Sustainability Finance

Software & Technology

Artificial Intelligence Automation Cloud IoT Robotics Software

The Academy

Executive Education Associations Institutions Universities & Colleges

Resources

Podcasts Webcasts Companies Visionaries White Papers Special Reports Premiums Magazine Archive

Subscribe

SCMR Magazine Newsletters Magazine Archives Customer Service